FDA Inspection
LEESAR, INCLEESAR, INC – FDA Inspection, Sep 23, 2026
Record Details
This FDA Inspection record concerns LEESAR, INC, with an inspection on September 23, 2026, issued by the Florida District Office, covering human drugs.
View Company Profile
ID · e4951ec0-3f11-4759-94f5-93eaf99c3861
Inspection Facts
- Inspection number
- 1337198
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of LEESAR, INC
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 18, 2025 | NAI | Florida District Office | Postmarket Assurance: Medical Devices |
| May 9, 2025 | VAI | Florida District Office | Drug Quality Assurance |
| October 29, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 12, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 8, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for LEESAR, INC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.